These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 25823008)

  • 21. An In Vitro Investigation of Platelet-Rich Plasma-Gel as a Cell and Growth Factor Delivery Vehicle for Tissue Engineering.
    Jalowiec JM; D'Este M; Bara JJ; Denom J; Menzel U; Alini M; Verrier S; Herrmann M
    Tissue Eng Part C Methods; 2016 Jan; 22(1):49-58. PubMed ID: 26467221
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Properties of 3 Different Plasma Formulations and Their Effects on Tendinopathic Cells.
    Rubio-Azpeitia E; Bilbao AM; Sánchez P; Delgado D; Andia I
    Am J Sports Med; 2016 Aug; 44(8):1952-61. PubMed ID: 27161868
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Platelet-rich preparations to improve healing. Part II: platelet activation and enrichment, leukocyte inclusion, and other selection criteria.
    Davis VL; Abukabda AB; Radio NM; Witt-Enderby PA; Clafshenkel WP; Cairone JV; Rutkowski JL
    J Oral Implantol; 2014 Aug; 40(4):511-21. PubMed ID: 25106017
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Autologous fibrin scaffolds: When platelet- and plasma-derived biomolecules meet fibrin.
    Anitua E; Nurden P; Prado R; Nurden AT; Padilla S
    Biomaterials; 2019 Feb; 192():440-460. PubMed ID: 30500725
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Platelet-rich plasma and platelet-rich fibrin in human cell culture.
    Gassling VL; Açil Y; Springer IN; Hubert N; Wiltfang J
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2009 Jul; 108(1):48-55. PubMed ID: 19451011
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High-throughput proteomic characterization of plasma rich in growth factors (PRGF-Endoret)-derived fibrin clot interactome.
    Anitua E; Prado R; Azkargorta M; Rodriguez-Suárez E; Iloro I; Casado-Vela J; Elortza F; Orive G
    J Tissue Eng Regen Med; 2015 Nov; 9(11):E1-12. PubMed ID: 23505226
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of leukocytes from L-PRP/L-PRF in wound healing and immune defense: new perspectives.
    Bielecki T; Dohan Ehrenfest DM; Everts PA; Wiczkowski A
    Curr Pharm Biotechnol; 2012 Jun; 13(7):1153-62. PubMed ID: 21740376
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fabrication and characterization of platelet-rich plasma scaffolds for tissue engineering applications.
    Sadeghi-Ataabadi M; Mostafavi-Pour Z; Vojdani Z; Sani M; Latifi M; Talaei-Khozani T
    Mater Sci Eng C Mater Biol Appl; 2017 Feb; 71():372-380. PubMed ID: 27987720
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Classification of platelet concentrates: from pure platelet-rich plasma (P-PRP) to leucocyte- and platelet-rich fibrin (L-PRF).
    Dohan Ehrenfest DM; Rasmusson L; Albrektsson T
    Trends Biotechnol; 2009 Mar; 27(3):158-67. PubMed ID: 19187989
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Leukocyte- and platelet-rich Plasma (L-PRP)/fibrin (L-PRF) in medicine - past, present, future.
    Bielecki T; Dohan Ehrenfest DM
    Curr Pharm Biotechnol; 2012 Jun; 13(7):i-ii. PubMed ID: 22709373
    [No Abstract]   [Full Text] [Related]  

  • 31. Does leukocyte-poor or leukocyte-rich platelet-rich plasma applied with biopolymers have superiority to conventional platelet-rich plasma applications on chondrocyte proliferation?
    Yaşar Şirin D; Yılmaz İ; İsyar M; Öznam K; Mahiroğulları M
    Eklem Hastalik Cerrahisi; 2017 Dec; 28(3):142-51. PubMed ID: 29125811
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A comparative study of platelet-rich fibrin (PRF) and platelet-rich plasma (PRP) on the effect of proliferation and differentiation of rat osteoblasts in vitro.
    He L; Lin Y; Hu X; Zhang Y; Wu H
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2009 Nov; 108(5):707-13. PubMed ID: 19836723
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An improved freeze-dried PRP-coated biodegradable material suitable for connective tissue regenerative therapy.
    Horimizu M; Kawase T; Nakajima Y; Okuda K; Nagata M; Wolff LF; Yoshie H
    Cryobiology; 2013 Jun; 66(3):223-32. PubMed ID: 23422785
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Incorporating platelet-rich plasma into electrospun scaffolds for tissue engineering applications.
    Sell SA; Wolfe PS; Ericksen JJ; Simpson DG; Bowlin GL
    Tissue Eng Part A; 2011 Nov; 17(21-22):2723-37. PubMed ID: 21679135
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Selecting a relevant in vitro cell model for testing and comparing the effects of a Choukroun's platelet-rich fibrin (PRF) membrane and a platelet-rich plasma (PRP) gel: tricks and traps.
    Dohan Ehrenfest DM; Del Corso M; Inchingolo F; Charrier JB
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Oct; 110(4):409-11; author reply 411-3. PubMed ID: 20868988
    [No Abstract]   [Full Text] [Related]  

  • 36. The differential effects of leukocyte-containing and pure platelet-rich plasma (PRP) on tendon stem/progenitor cells - implications of PRP application for the clinical treatment of tendon injuries.
    Zhou Y; Zhang J; Wu H; Hogan MV; Wang JH
    Stem Cell Res Ther; 2015 Sep; 6(1):173. PubMed ID: 26373929
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The basic science of platelet-rich plasma (PRP): what clinicians need to know.
    Arnoczky SP; Sheibani-Rad S
    Sports Med Arthrosc Rev; 2013 Dec; 21(4):180-5. PubMed ID: 24212364
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Shedding light in the controversial terminology for platelet-rich products: platelet-rich plasma (PRP), platelet-rich fibrin (PRF), platelet-leukocyte gel (PLG), preparation rich in growth factors (PRGF), classification and commercialism.
    Dohan Ehrenfest DM; Bielecki T; Del Corso M; Inchingolo F; Sammartino G
    J Biomed Mater Res A; 2010 Dec; 95(4):1280-2. PubMed ID: 20925082
    [No Abstract]   [Full Text] [Related]  

  • 39. Tissue augmentation by white blood cell-containing platelet-rich plasma.
    Kawazoe T; Kim HH
    Cell Transplant; 2012; 21(2-3):601-7. PubMed ID: 22793069
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characteristics of an autologous leukocyte and platelet-rich fibrin patch intended for the treatment of recalcitrant wounds.
    Lundquist R; Holmstrøm K; Clausen C; Jørgensen B; Karlsmark T
    Wound Repair Regen; 2013; 21(1):66-76. PubMed ID: 23230828
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.